BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Xbiotech Announces Positive Results In European Phase III Study For Its Breakthrough Therapy For Colorectal Cancer

  December 7, 2015

   · 

  5 min read
• Drug Development

  Intercept Pharma Announces Initiation Of Prospective Trial To Explore Effect Of Combined OCA And Statin Therapy On Lipid Metabolism In NASH Patients

  December 7, 2015

   · 

  8 min read
• Biotech Bay

  Vapir Enterprises Is Granted Its Sixth U.S. Patent

  December 7, 2015

   · 

  2 min read
• Drug Development

  CTI BioPharma Release: Analysis Of Pivotal Phase 3 Patient Outcomes By Subgroups Shows Treatment With Pacritinib Resulted In Consistent Rates Of Reduction In Spleen Volume And Symptom Burden

  December 7, 2015

   · 

  12 min read
• Drug Development

  AbbVie Release: Ibrutinib (IMBRUVICA) Improves Survival In Treatment-Naive Chronic Lymphocytic Leukemia Patients In The Phase 3 RESONATE-2 Trial

  December 7, 2015

   · 

  14 min read
• Drug Development

  AbbVie Reports Phase 2 Results Of Venetoclax In Relapsed/Refractory Chronic Lymphocytic Leukemia Patients With 17p Deletion

  December 7, 2015

   · 

  8 min read
• Business

  ImmunoCellular Therapeutics, Ltd Establishes Agreement With Alliance Foundation Trials, LLC For ICT-107 Phase 3 Registrational Trial In Glioblastoma

  December 7, 2015

   · 

  3 min read
• Drug Development

  Astellas Announces Updated Data From The Phase 1/2 CHRYSALIS Trial For Gilteritinib (ASP2215) In Patients With Relapsed Or Refractory Acute Myeloid Leukemia

  December 7, 2015

   · 

  3 min read
• Drug Development

  Amgen Release: Pivotal Head-To-Head ENDEAVOR Study Results Published In The Lancet Oncology Demonstrate Superiority Of Kyprolis (carfilzomib) Combination Over Velcade (bortezomib) Combination

  December 7, 2015

   · 

  8 min read
• Drug Development

  CTI BioPharma Release: Analysis Of Phase 2 Tosedostat In Combination With Low Dose Cytarabine Shows High Rates Of Response In Elderly Patients With AML

  December 7, 2015

   · 

  8 min read